Circulating and tumor-based biomarkers predict clinical activity in cancer patients treated with the engineered anti-PD-L1 antibody MPDL3280A. (6th November 2014)

• Record Type: Journal Article
• Authors: Kowanetz, Marcin; Rabe, Christina; Xiao, Yuanyuan; Wu, Qun J; Koeppen, Hartmut; Leddy, Cecilia; Patel, Rajesh D; Powderly, John; Kohrt, Holbrook; Gettinger, Scott; Soria, Jean-Charles; Herbst, Roy S; Desai, Rupal; Denker, Mitchell; Ruppel, Jane; Boe, Marigold; Nakamura, Rin; Fu, Ling; Sumiyoshi, Teiko; Mokatrin, Ahmad; Shen, Xiaodong; Fine, Gregg; Chen, Daniel S; Hegde, Priti S
• Is Part Of: Journal for immunotherapy of cancer. Volume 2(2014)Supplement 3
• Publication Date: 2014-11-06
• Subjects: Immune Checkpoint -- Checkpoint Inhibition -- Cell Alpha -- Immune Checkpoint Inhibition -- Multiple Tumor Type; Cancer -- Immunotherapy -- Periodicals; Cancer -- Immunological aspects -- Periodicals; Tumors -- Immunological aspects -- Periodicals; Immunotherapy -- Periodicals; 616.99406105
• DOI: 10.1186/2051-1426-2-S3-P136
• Languages: English
• ISSNs: 2051-1426